Latest News from ASCO in Action

Latest News from ASCO in Action

December 23, 2014

Congress has passed, and the President has signed, the “Achieving a Better Life Experience Act,” which will allow individuals with disabilities to create tax-free savings accounts, while protecting their access to Medicaid. ASCO does not oppose the intent and goals of the underlying legislation, however, the society does object to Congress offsetting the cost of the law with nearly $1.2 billion in cuts to Medicare physician reimbursement, adding yet further instability to an already fundamentally broken system that threatens high-quality cancer care for millions of Medicare patients.

December 23, 2014

ASCO has submitted comments to the U.S. Office for Human Research Protections regarding a draft guidance, “Disclosing Reasonably Foreseeable Risks in Research Evaluating Standards of Care.”

December 22, 2014

On December 22, 2014, the U. S. Food and Drug Administration granted accelerated approval to nivolumab (OPDIVO, Bristol-Myers Squibb Company) for the treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF inhibitor.

ASCO's ACT Network

ASCO's ACT Network

ALERT CONGRESS TODAY! Use ASCO's ACT Network to contact your elected officials on important policy issues impacting cancer care. 

ASCO Issue Backgrounders

ASCO Issue Backgrounders

ASCO offers issue backgrounders to help provide an overview of the major policy issues that impact patients with cancer and the physicians who care for them. The issue backgrounders cover topics such as reimbursement, health equity, cancer research funding, and more.

Click here to read the backgrounds and help develop your understanding of cancer policy issues.

NIH Funding Educational Series

NIH Funding Educational Series

ASCO explores the decade-long decline in federal funding for cancer research – and why this decline must be reversed. Read more here.